James A. Crowell - Concepedia

Author

James A. Crowell

Also Known As

J A Crowell, J CROWELL, J Crowell, J. A. Crowell, J. Crowell, J.A. Crowell, JAMES A. CROWELL, JAMES CROWELL, James A Crowell, James A. Crowell

276

Publications

17.5K

Citations

H-Index

189

Concepts

All Affiliations

National Cancer Institute University of Illinois Urbana-Champaign National Institutes of Health University of California, Berkeley University of Arizona

About

James A. Crowell is an author at National Cancer Institute specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	55	6.3K
2	Engineering	8	8	852
3	Health Sciences	3	3	198
4	Education	2	2	41
5	Language Studies	1	1	68

James A. Crowell

126

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
Dose escalation of a curcuminoid formulation Christopher D. Lao, Mack T. Ruffin, Daniel P. Normolle, BMC Complementary and Alternative Medicine	2006	1.4K
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent David J. Boocock, Guy Faust, Ketan Patel, Cancer Epidemiology Biomarkers & Prevention	2007	808
Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. H.‐H. Sherry Chow, Yan Cai, Iman A. Hakim, PubMed	2003	708
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis Victoria Brown, Ketan Patel, Maria Viskaduraki, Cancer Research Chemoprevention StrategyNutraceutical IngredientCancer Chemopreventive PropertiesPathologyPharmacotherapy	2010	664
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients Ketan Patel, Victoria Brown, Donald J. L. Jones, Cancer Research Chemoprevention StrategyMedicinePharmacologyColorectal CancerPathology	2010	604
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects Shaiju K. Vareed, Madhuri Kakarala, Mack T. Ruffin, Cancer Epidemiology Biomarkers & Prevention	2008	556
A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Kenneth G. Miller, Minh Nguyen, James A. Crowell, Proceedings of the National Academy of Sciences EngineeringGeneticsSynaptic TransmissionNeurotransmitterMolecular Biology	1996	440
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. H.‐H. Sherry Chow, Yan Cai, David S. Alberts, PubMed Tea PolyphenolsEgcg ContentFood Bioactive CompoundChemoprevention StrategyPolyphenon E	2001	419
Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals H.‐H. Sherry Chow, Iman A. Hakim, Donna R. Vining, Clinical Cancer Research	2005	396
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity Susan L. Holbeck, Richard F. Camalier, James A. Crowell, Cancer Research	2017	375

Page 1